Dasatinib Receives FDA Approval for Pediatric Ph+ Acute Lymphoblastic Leukemia

Press/Media

Period	2 Jan 2019

Media coverage

Title	Dasatinib Receives FDA Approval for Pediatric Ph+ Acute Lymphoblastic Leukemia
Media name/outlet	MedicalHealthNews.net
Country/Territory	Turkey
Date	2/01/19
URL	www.medicalhealthnews.net/dasatinib-receives-fda-approval-for-bpediatricb-ph-acute-lymphoblastic-leukemia
Persons	Stephen Hunger